IP Library Granted Patent US 10,087,419
Granted Patent B2
US 10,087,419 · App. 14/925,508 · Granted Oct 2, 2018

Method for producing differentiated cells

Inventors: Koji Eto (Kyoto, JP); Naoya Takayama (Kyoto, JP); Sou Nakamura (Tokyo, JP); Hiromitsu Nakauchi (Tokyo, JP)
Assignee: The University of Tokyo
C12N5/0641C12N5/0644A61K35/00C12N2501/40C12N2501/48C12N2501/60C12N2501/606C12N2506/02C12N2506/45
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,087,419
App. No.
14/925,508
Granted
Oct 2, 2018
Kind
B2
Abstract

The present invention has an object of providing a method for producing specific cells by amplifying cells in a desired differentiation stage. The present invention provides a method for producing specific cells by inducing differentiation of cells, wherein an oncogene is forcibly expressed in cells in a desired differentiation stage to amplify the cells in the desired differentiation stage. The present invention also provides a method for producing specific cells, wherein oncogene-induced senescence (OIS) which is induced by the oncogene expressed in the cells in the desired differentiation stage is suppressed.

Claims (7)

1. A method of producing erythroid cells comprising:

introducing and expressing a nucleic acid encoding MYC and one of a nucleic acid encoding HOXA2 and a nucleic acid encoding BCLXL in hematopoietic progenitor cells and amplifying the cells by culturing to obtain erythroid progenitor cells; and

differentiating the erythroid progenitor cells into erythroid cells.

2. The method of claim 1 further comprising cryopreserving the amplified cells after the step of amplifying,

wherein the step of differentiating is performed after the cryopreserved cells are thawed.

3. The method according to claim 1 , wherein the nucleic acid is comprised in an expression vector.

4. The method according to claim 3 , wherein the nucleic acid encoding MYC is a nucleic acid encoding c-MYC.

Priority Claims (1)
JP 2009-213645 · Sep 15, 2009 · national
Continuity (2)
Division 13496321
Related Publication 20160115449A1 · Apr 28, 2016
Cited By (1)
US 12,698,255